"Anemia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A reduction in the number of circulating ERYTHROCYTES or in the quantity of HEMOGLOBIN.
Descriptor ID |
D000740
|
MeSH Number(s) |
C15.378.071
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Anemia".
Below are MeSH descriptors whose meaning is more specific than "Anemia".
This graph shows the total number of publications written about "Anemia" by people in this website by year, and whether "Anemia" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 1 | 0 | 1 |
1999 | 0 | 1 | 1 |
2001 | 1 | 0 | 1 |
2002 | 0 | 1 | 1 |
2005 | 3 | 1 | 4 |
2006 | 2 | 0 | 2 |
2007 | 9 | 1 | 10 |
2008 | 13 | 1 | 14 |
2009 | 7 | 1 | 8 |
2010 | 10 | 0 | 10 |
2011 | 1 | 2 | 3 |
2012 | 3 | 2 | 5 |
2013 | 1 | 1 | 2 |
2014 | 1 | 0 | 1 |
2016 | 0 | 1 | 1 |
2017 | 3 | 3 | 6 |
2018 | 1 | 2 | 3 |
2019 | 1 | 2 | 3 |
2020 | 0 | 1 | 1 |
2021 | 2 | 0 | 2 |
2022 | 8 | 0 | 8 |
2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Anemia" by people in Profiles.
-
Regional Variation of Erythropoiesis-Stimulating Agent Hyporesponsiveness in the Global Daprodustat Dialysis Study (ASCEND-D). Am J Nephrol. 2023; 54(1-2):1-13.
-
Daprodustat and On-Treatment Cardiovascular Events in Chronic Kidney Disease. Reply. N Engl J Med. 2022 12 29; 387(26):2482-2485.
-
The ASCEND-ND trial: study design and participant characteristics. Nephrol Dial Transplant. 2022 10 19; 37(11):2157-2170.
-
Three Times Weekly Dosing of Daprodustat versus Conventional Epoetin for Treatment of Anemia in Hemodialysis Patients: ASCEND-TD: A Phase 3 Randomized, Double-Blind, Noninferiority Trial. Clin J Am Soc Nephrol. 2022 09; 17(9):1325-1336.
-
HDFN Resulting from Anti-U: Alternatives to Allogeneic Intrauterine Transfusion. Lab Med. 2022 Jul 04; 53(4):e79-e82.
-
Efficacy and Safety of Daprodustat for Treatment of Anemia of Chronic Kidney Disease in Incident Dialysis Patients: A Randomized Clinical Trial. JAMA Intern Med. 2022 06 01; 182(6):592-602.
-
Eliminate Unnecessary Laboratory Work to Mitigate Iatrogenic Anemia and Reduce Cost for Patients on Extracorporeal Membrane Oxygenation. J Extra Corpor Technol. 2022 Jun; 54(2):123-127.
-
Study design and baseline characteristics of patients on dialysis in the ASCEND-D trial. Nephrol Dial Transplant. 2022 04 25; 37(5):960-972.
-
Debate: Are HIF Stabilizers a Viable Alternative to ESAs in the Management of Anemia in CKD? PRO. Am J Nephrol. 2022; 53(5):361-365.
-
Daprodustat for the Treatment of Anemia in Patients Undergoing Dialysis. N Engl J Med. 2021 12 16; 385(25):2325-2335.